Images List Premium Download Classic

Prophylactic

Prophylactic-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
NEW Rna-based compositions and adjuvants for prophylactic and therapeutic treatment
University Of Kentucky Research Foundation
June 22, 2017 - N°20170175122

The present invention is directed towards an artificial rna nanostructure comprising multiple external strands of rna, each external strand comprising about 40-50 nucleotides; one internal strand of rna comprising more than about 50 nucleotides; the internal strands and external strands assembled to form a triangle nanostructure, a square nanostructure, or a polygon nanostructure and a prna three-way junction (3wj) motif at ...
NEW Anti-tie2 antibodies and uses thereof
Regeneron Pharmaceuticals, Inc.
June 22, 2017 - N°20170174789

The present invention provides antibodies that bind to tie2 and methods of using same. According to certain embodiments of the invention, the antibodies are fully human antibodies that bind to human tie2 and block the interaction between tie2 and one or more tie2 ligands such as angiopoietin 1 (ang1), angiopoietin 2 (ang2), angiopoietin 3 (ang3) and/or angiopoietin 4 (ang4). The antibodies of the ...
NEW Polypeptides, antibody variable domains and antagonists
Domantis Limited
June 22, 2017 - N°20170174775

The invention relates to anti-tnfr1 polypeptides and antibody single variable domains (dabs) that are resistant to degradation by a protease, as well as antagonists comprising these. The polypeptides, dabs and antagonists are useful for as therapeutics and/or prophylactics that are likely to encounter proteases when administered to a patient, for example for pulmonary administration, oral administration, delivery to the ...
NEW Prophylactic Patent Pack
Download 224+ patent application PDFs
Prophylactic Patent Applications
Download 224+ Prophylactic-related PDFs
For professional research & prior art discovery
inventor
  • 224+ full patent PDF documents of Prophylactic-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
NEW Pharmaceutical composition containing pregabalin with improved stability and method for preparing same
Yungjin Pharm. Co., Ltd.
June 22, 2017 - N°20170172929

Provided are a sustained-release composition including pregabalin and a pharmaceutically acceptable salt thereof using a gastroretentive drug delivery system (grdds), an oral sustained-release formulation using the composition, and a preparation method thereof. In a sustained-release composition according to the present invention and a formulation including the same, a coating compartment including a sugar or a derivative thereof and a plasticizer ...
NEW Preventive or therapeutic agent for kidney disease
Miyazaki, Toru
June 22, 2017 - N°20170172120

The present invention provides a prophylactic or therapeutic agent for a kidney disease, comprising aim or a partial peptide thereof, or a nucleic acid comprising a base sequence encoding the same, or a screening method for a prophylactic or therapeutic agent for a kidney disease, comprising using an animal obtained by subjecting a non-human mammal deficient in aim expression to ...
Amino acid sequences directed against rank-l and polypeptides comprising the same for the treatment of ...
Ablynx N.v.
June 15, 2017 - N°20170166647

The present invention relates to amino acid sequences that are directed against rank-l, as well as to compounds or constructs, and in particular proteins and polypeptides, that comprise or essentially consist of one or more such amino acid sequences. The invention also relates to nucleic acids encoding such amino acid sequences and polypeptides; to methods for preparing such amino acid ...
Prophylactic Patent Pack
Download 224+ patent application PDFs
Prophylactic Patent Applications
Download 224+ Prophylactic-related PDFs
For professional research & prior art discovery
inventor
  • 224+ full patent PDF documents of Prophylactic-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Helicobacter therapeutic
Murdoch Childrens Research Institute
June 15, 2017 - N°20170165347

The present invention relates to method of treating and/or preventing inflammation in a subject caused by bacteria that express htra. The present invention further relates to immunogenic compositions comprising an htra polypeptide or fragment thereof, as well as a therapeutic and/or prophylactic vaccine for treating or preventing disease.
Selective sphingosine 1 phosphate receptor modulators and combination therapy therewith
Celgene International Ii Sàrl
June 15, 2017 - N°20170165236

Compounds that selectively modulate the sphingosine 1 phosphate receptor are provided, including compounds which modulate subtype 1 of the s1p receptor, and methods of their therapeutic and/or prophylactic use in combination with at least one other medicament adapted for treatment of a malcondition for which activation of s1p1 is medically indicated, such as multiple sclerosis.
Ph-responsive mucoadhesive polymeric encapsulated microorganisms
Massachusetts Institute Of Technology
June 15, 2017 - N°20170165201

Methods of encapsulating microorganisms, or components thereof, for targeted enteric delivery to an animal host have been developed. In particular, the encapsulation provides a prolonged survival, extended retention and a ph-sensitive release of the encapsulated microorganisms or antigenic components thereof at targeted sites within the gastrointestinal tract. The formulations are useful for diagnostic, therapeutic and prophylactic purposes and can alter ...
Methods for providing prophylactic surface treatment for fluid processing systems and components thereof
C3 International, Llc
June 08, 2017 - N°20170159870

The invention relates to a method for creating a diffused thin film surface treatments on one or more interior surfaces of closed or partially closed fluid transport or processing systems providing improved surface prophylaxis against fouling. The method involves contacting the interior surfaces to be treated with a metal compound composition, and converting the metal compound composition to metal oxide ...
Vaccine against porcine circo virus type 2
Intervet Inc.
June 08, 2017 - N°20170157236

The present invention pertains to a vaccine comprising a non-replicating immunogen of porcine circo virus type 2 for use in prophylactically treating an animal that has circulating antibodies directed against porcine circo virus type 2, against an infection with pathogenic porcine circo virus type 2 by a single dose administration of the vaccine into the dermis of the animal.
Vaccines and compositions against streptococcus pneumoniae
Children's Medical Center Corporation
June 08, 2017 - N°20170157234

Streptococcus pneumoniae is a major health concern, especially in very young, elderly, or immunocompromised patients. The present disclosure provides, inter alia, certain highly effective vaccines and pharmaceutical compositions in streptococcus pneumoniae. The antigens may be used therapeutically or prophylactically.
Methods of treating zika virus, mers-cov, chikungunya, venezuelan equine encephalitus, and rhinovirus in mammalian patients
Tamir Biotechnology, Inc.
June 08, 2017 - N°20170157219

Viral infections in mammals can be treated and prophylactically prevented by systemic administration of ranpirnase and three other ribonucleases that are highly homologous with it and that have activities that are highly similar to it. Experimental results against zika virus, middle east respiratory syndrome coronavirus (“mers-cov”), chikungunya virus, venezuelan equine encephalitis, and rhinovirus-14 are disclosed.
Prophylactic Patent Pack
Download 224+ patent application PDFs
Prophylactic Patent Applications
Download 224+ Prophylactic-related PDFs
For professional research & prior art discovery
inventor
  • 224+ full patent PDF documents of Prophylactic-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Methods and compositions for treatment of disorders associated with damage induced by free radicals
Glycadia, Inc.
June 08, 2017 - N°20170157010

The present invention relates to treatment of various disorders, diseases or conditions associated with or mediated by oxidative stress arising from an imbalance between the production of and the ability to neutralize reactive free radicals. The present invention is directed to methods and compositions capable of scavenging reactive free radicals for therapeutically or prophylactically treating disorders associated with free radical-induced ...
Antibodies and antigen-binding fragments that specifically bind to microtubule-associated protein tau
Janssen Vaccines & Prevention B.v.
June 01, 2017 - N°20170152307

The disclosure relates to antibodies and antigen-binding fragments that specifically bind to microtubule-associated protein tau. The disclosure also relates to diagnostic, prophylactic and therapeutic methods using anti-tau antibodies.
Nitrogen-containing aromatic heterocyclic compound
Kotobuki Pharmaceutical Co., Ltd.
June 01, 2017 - N°20170152232

As a result of studies on compounds having fgfr inhibitory action, the present inventors have found that the nitrogen-containing aromatic heterocyclic compounds of the present invention have inhibitory action on fgfr1, fgfr2, and/or fgfr3, particularly, mutant fgfr3, and thus, the present invention has been accomplished. The nitrogen-containing aromatic heterocyclic compound of the present invention can be used as a ...
Targeted conjugates and particles and formulations thereof
Tarveda Therapeutics, Inc.
June 01, 2017 - N°20170151339

Particles, including nanoparticles and microparticles, and pharmaceutical formulations thereof, comprising conjugates of an active agent such as a therapeutic, prophylactic, or diagnostic agent attached to a targeting moiety via a linker have been designed which can provide improved temporospatial delivery of the active agent and/or improved biodistribution. Methods of making the conjugates, the particles, and the formulations thereof are ...
Composition for preventing the occurrence of cardiovascular event in multiple risk patient
Mochida Pharmaceutical Co., Ltd.
June 01, 2017 - N°20170151206

Disclosed is a composition which is useful for preventing the occurrence of a cardiovascular event, particularly a composition which is expected to show a prophylactic effect on a cardiovascular event occurring in a hypercholesterolemia patient despite providing the patient with a treatment with hmg-coa ri or a cardiovascular event occurring in a multiple risk patient.
Prophylactic or therapeutic agent for idiopathic inflammatory myopathies
National University Corporation Tokyo Medical And Dental University
June 01, 2017 - N°20170151200

Administration of isoleucine, leucine and valine is effective for the prophylaxis and/or therapy of idiopathic inflammatory myopathy or idiopathic inflammatory myopathy associated with steroid-induced myopathy that develops during the course of treatment. This method is effective for the prophylaxis and/or therapy of idiopathic inflammatory myopathy or idiopathic inflammatory myopathy associated with steroid-induced myopathy that develops during the course ...
Compositions and methods for otologic prophylaxis and treatment
Otic Pharma Inc.
June 01, 2017 - N°20170151173

A prophylactic method for preventing otitis media or eustachian tube dysfunction, or reducing the severity of symptoms thereof, decreasing the risk of future otitis media, with or without ear infection, and associated effects including acute or permanent hearing loss, speech and balance problems, behavior problems and sleep problems caused by acute, intermittent episodic, recurrent or chronic otitis media, and the ...
Method of generating multilineage potential cells from lymphocytes
Otic Pharma Inc.
May 25, 2017 - N°20170145381

The present invention relates generally to a method of generating cells exhibiting multilineage potential and to cells generated thereby. More particularly, the present invention is directed to an in vitro method of generating mammalian stem cells from cd4* mononuclear cells, cd8* mononuclear cells, cd25* mononuclear cells, cd19* mononuclear cells or cd20* mononuclear cells and to cells generated thereby. This finding ...
Loading